Yungjin Pharm. Co., Ltd. - Product Pipeline Review - 2016

Yungjin Pharm. Co., Ltd. - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘Yungjin Pharm. Co., Ltd. - Product Pipeline Review - 2016’, provides an overview of the Yungjin Pharm. Co., Ltd.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Yungjin Pharm. Co., Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Yungjin Pharm. Co., Ltd.
  • The report provides overview of Yungjin Pharm. Co., Ltd. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Yungjin Pharm. Co., Ltd.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Yungjin Pharm. Co., Ltd.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate Yungjin Pharm. Co., Ltd.’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Yungjin Pharm. Co., Ltd.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Yungjin Pharm. Co., Ltd.’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Yungjin Pharm. Co., Ltd. Snapshot
Yungjin Pharm. Co., Ltd. Overview
Key Information
Key Facts
Yungjin Pharm. Co., Ltd. - Research and Development Overview
Key Therapeutic Areas
Yungjin Pharm. Co., Ltd. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Yungjin Pharm. Co., Ltd. - Pipeline Products Glance
Yungjin Pharm. Co., Ltd. - Late Stage Pipeline Products
Pre-Registration Products/Combination Treatment Modalities
Phase III Products/Combination Treatment Modalities
Yungjin Pharm. Co., Ltd. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Yungjin Pharm. Co., Ltd. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Yungjin Pharm. Co., Ltd. - Drug Profiles
(acetaminophen + tramadol hydrochloride) SR
Product Description
Mechanism of Action
R&D Progress
YBH-1603
Product Description
Mechanism of Action
R&D Progress
YPL-001
Product Description
Mechanism of Action
R&D Progress
YNP-1707
Product Description
Mechanism of Action
R&D Progress
YOB-1604
Product Description
Mechanism of Action
R&D Progress
ceftaroline fosamil
Product Description
Mechanism of Action
R&D Progress
YLS-1501
Product Description
Mechanism of Action
R&D Progress
YRA-1909
Product Description
Mechanism of Action
R&D Progress
YSA-2021
Product Description
Mechanism of Action
R&D Progress
YAC-1912
Product Description
Mechanism of Action
R&D Progress
YMS-1716
Product Description
Mechanism of Action
R&D Progress
YPC-1811
Product Description
Mechanism of Action
R&D Progress
YPP-2022
Product Description
Mechanism of Action
R&D Progress
YTD-2020
Product Description
Mechanism of Action
R&D Progress
Yungjin Pharm. Co., Ltd. - Pipeline Analysis
Yungjin Pharm. Co., Ltd. - Pipeline Products by Target
Yungjin Pharm. Co., Ltd. - Pipeline Products by Route of Administration
Yungjin Pharm. Co., Ltd. - Pipeline Products by Molecule Type
Yungjin Pharm. Co., Ltd. - Pipeline Products by Mechanism of Action
Yungjin Pharm. Co., Ltd. - Dormant Projects
Yungjin Pharm. Co., Ltd. - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Yungjin Pharm. Co., Ltd., Key Information
Yungjin Pharm. Co., Ltd., Key Facts
Yungjin Pharm. Co., Ltd. - Pipeline by Indication, 2016
Yungjin Pharm. Co., Ltd. - Pipeline by Stage of Development, 2016
Yungjin Pharm. Co., Ltd. - Monotherapy Products in Pipeline, 2016
Yungjin Pharm. Co., Ltd. - Combination Treatment Modalities in Pipeline, 2016
Yungjin Pharm. Co., Ltd. - Pre-Registration, 2016
Yungjin Pharm. Co., Ltd. - Phase III, 2016
Yungjin Pharm. Co., Ltd. - Phase II, 2016
Yungjin Pharm. Co., Ltd. - Phase I, 2016
Yungjin Pharm. Co., Ltd. - Preclinical, 2016
Yungjin Pharm. Co., Ltd. - Discovery, 2016
Yungjin Pharm. Co., Ltd. - Pipeline by Target, 2016
Yungjin Pharm. Co., Ltd. - Pipeline by Route of Administration, 2016
Yungjin Pharm. Co., Ltd. - Pipeline by Molecule Type, 2016
Yungjin Pharm. Co., Ltd. - Pipeline Products by Mechanism of Action, 2016
Yungjin Pharm. Co., Ltd. - Dormant Developmental Projects,2016
ist of Figures
Yungjin Pharm. Co., Ltd. - Pipeline by Top 10 Indication, 2016
Yungjin Pharm. Co., Ltd. - Pipeline by Stage of Development, 2016
Yungjin Pharm. Co., Ltd. - Monotherapy Products in Pipeline, 2016
Yungjin Pharm. Co., Ltd. - Pipeline by Target, 2016
Yungjin Pharm. Co., Ltd. - Pipeline by Route of Administration, 2016
Yungjin Pharm. Co., Ltd. - Pipeline by Molecule Type, 2016
Yungjin Pharm. Co., Ltd. - Pipeline Products by Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook